Feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy for patients with high risk or locally advanced prostate cancer: results of a phase I/II study.

作者: BADRINATH R. KONETY , JAMES A. EASTHAM , VICTOR E. REUTER , PETER T. SCARDINO , S. MACHELE DONAT

DOI: 10.1097/01.JU.0000108122.36893.5A

关键词:

摘要: ABSTRACTPurpose: We determined the feasibility of radical prostatectomy after neoadjuvant chemohormonal therapy in locally advanced (stage T3 or greater) and/or high risk tumors (Gleason 8 to 10 serum prostate specific antigen (PSA) greater than 20 ng/ml).Materials and Methods: Enrollment criteria included clinical stage T1 2 with any Gleason grade PSA ng/ml, 4 grade, biopsy PSA. All patients received hormonal during chemotherapy (4 cycles paclitaxel carboplatin estramustine) followed by prostatectomy. Nerve sparing was decided on an individual basis a nerve graft offered those who underwent unilateral bilateral resection. Perioperative morbidity, mortality delayed complications were assessed.Results: A total 36 enrolled. After less 39% of...

参考文章(17)
A W Partin, P C Walsh, J I Epstein, C R Pound, J Q Clemens, Serum PSA after anatomic radical prostatectomy. The Johns Hopkins experience after 10 years Urologic Clinics of North America. ,vol. 20, pp. 713- 725 ,(1993) , 10.1016/S0094-0143(21)00924-1
Misop Han, Alan W. Partin, Charles R. Pound, Jonathan I. Epstein, Patrick C. Walsh, Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience. Urologic Clinics of North America. ,vol. 28, pp. 555- 565 ,(2001) , 10.1016/S0094-0143(05)70163-4
Mark S. Soloway, Roohollah Sharifi, Zev Wajsman, David McLeod, David P. Jr. Wood, Antonio for the Lupron Depot Neoadj Puras-Baez, Randomized Prospective Study Comparing Radical Prostatectomy Alone Versus Radical Prostatectomy Preceded by Androgen Blockage in Clinical Stage B2 (T2bNxM0) Prostate Cancer The Journal of Urology. ,vol. 154, pp. 424- 428 ,(1995) , 10.1016/S0022-5347(01)67067-8
EDWARD D. KIM, PETER T. SCARDINO, ORI HAMPEL, NOEL L. MILLS, THOMAS M. WHEELER, RAHUL K. NATH, Interposition of sural nerve restores function of cavernous nerves resected during radical prostatectomy. The Journal of Urology. ,vol. 161, pp. 188- 192 ,(1999) , 10.1016/S0022-5347(01)62093-7
S. Larry Goldenberg, Laurence H. Klotz, John Srigley, Michael A.S. Jewett, David Mador, Yves Fradet, Jack Barkin, Joseph Chin, Jean-Marie Paquin, Martin J. Bullock, Suzanne Laplante, Randomized, prospective, controlled study comparing radical prostatectomy alone and neoadjuvant androgen withdrawal in the treatment of localized prostate cancer The Journal of Urology. ,vol. 156, pp. 873- 877 ,(1996) , 10.1016/S0022-5347(01)65645-3
Curtis J. Mettlin, Gerald P. Murphy, David S. Rosenthal, Herman R. Menck, The National Cancer Data Base Report on Prostate Carcinoma after the Peak in Incidence Rates in the U. S. Cancer. ,vol. 83, pp. 1679- 1684 ,(1998) , 10.1002/(SICI)1097-0142(19981015)83:8<1679::AID-CNCR24>3.0.CO;2-Y
Anthony L. Zietman, John J. Coen, Katherine C. Dallow, William U. Shipley, The treatment of prostate cancer by conventional radiation therapy: An analysis of long-term outcome International Journal of Radiation Oncology Biology Physics. ,vol. 32, pp. 287- 292 ,(1995) , 10.1016/0360-3016(95)00123-G
DIES van den OUDEN, WIM C.J. HOP, FRITZ H. SCHRODER, PROGRESSION IN AND SURVIVAL OF PATIENTS WITH LOCALLY ADVANCED PROSTATE CANCER (T3) TREATED WITH RADICAL PROSTATECTOMY AS MONOTHERAPY The Journal of Urology. ,vol. 160, pp. 1392- 1397 ,(1998) , 10.1016/S0022-5347(01)62546-1
Peter E Clark, David M Peereboom, Robert Dreicer, Howard S Levin, Sarah B Clark, Eric A Klein, Phase II trial of neoadjuvant estramustine and etoposide plus radical prostatectomy for locally advanced prostate cancer Urology. ,vol. 57, pp. 281- 285 ,(2001) , 10.1016/S0090-4295(00)00914-6